Immunologic Monitoring of Cancer Vaccine Trials Using the ELISPOT Assay

We present the Interferon (IFN)-γ-producing lymphocyte assay, but the platform is easily adjusted to several cell types and several secreted molecules.
Source: Springer protocols feed by Cancer Research - Category: Cancer & Oncology Source Type: news